Eris Lifesciences Limited
ERIS · 540596 · Healthcare · Pharmaceuticals
- Market cap
- Rs 16,520 Cr
- P/E
- 25.35x
- P/B
- 4.23x
- 52W high / low
- Rs 1,740 / Rs 1,180.1
Our computed roe (19.06%) diverges from BSE's own published figure (9.47%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (20.61%) diverges from BSE's own published figure (-3.10%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Torrent Pharmaceuticals Limited | Rs 4,800 | Rs 1,62,461 Cr | Rs 15,654 Cr | Rs 2,156 Cr | 76.68x | 27.30% |
| Zydus Lifesciences Limited | Rs 1,162 | Rs 1,15,968 Cr | Rs 29,052 Cr | Rs 4,593 Cr | 25.90x | 17.68% |
| Cipla Limited | Rs 1,346 | Rs 1,08,737 Cr | Rs 29,159 Cr | Rs 3,356 Cr | 32.25x | 10.27% |
| Laurus Labs Limited | Rs 1,980 | Rs 1,06,970 Cr | Rs 7,323 Cr | Rs 1,091 Cr | 97.73x | 22.38% |
| Mankind Pharma Limited | Rs 2,503.8 | Rs 1,03,407 Cr | Rs 15,062 Cr | Rs 2,068 Cr | 50.59x | 13.50% |
| Dr. Reddy's Laboratories Limited | Rs 1,233 | Rs 1,02,956 Cr | Rs 34,651 Cr | Rs 3,183 Cr | 31.87x | 9.02% |
| Aurobindo Pharma Limited | Rs 1,672 | Rs 96,207 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 26.13x | 10.53% |
| Lupin Limited | Rs 2,030.2 | Rs 92,831 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 16.78x | 27.89% |
| Glenmark Pharmaceuticals Limited | Rs 2,334.7 | Rs 65,885 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 36.65x | 15.46% |
| Alkem Laboratories Limited | Rs 5,163.5 | Rs 61,730 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 28.62x | 16.72% |
| Biocon Limited | Rs 370.3 | Rs 60,344 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Abbott India Limited | Rs 27,125 | Rs 57,641 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 35.70x | 35.85% |
| IPCA Laboratories Limited | Rs 1,927 | Rs 48,888 Cr | Rs 10,293 Cr | Rs 1,375 Cr | 37.32x | 17.45% |
| Gland Pharma Limited | Rs 2,899.4 | Rs 47,829 Cr | Rs 7,045 Cr | Rs 1,129 Cr | 42.32x | 11.57% |
| GlaxoSmithKline Pharmaceuticals Limited | Rs 2,769.3 | Rs 46,915 Cr | Rs 4,100 Cr | Rs 1,068 Cr | 44.66x | 50.64% |
| Eris Lifesciences LimitedThis company | Rs 1,191.9 | Rs 16,520 Cr | Rs 3,237 Cr | Rs 666 Cr | 25.35x | 19.06% |
| Median | Rs 2,005.1 | Rs 94,519 Cr | Rs 15,358 Cr | Rs 2,112 Cr | 33.97x | 17.57% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.